Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut

Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.

More In Business

Expedia cites lower demand for US travel for weaker revenue

Travel technology company Expedia Group says reduced travel demand in the United States led to its weaker-than-expected revenue in the first quarter.

Taylor Morrison CEO Sheryl Palmer on How Tariff Uncertainty Will Affect Real Estate Market

Sheryl Palmer, CEO of Taylor Morrison, talks tariff uncertainty, being a female leader in a male dominated industry and what homebuyers need to know. Watch!

Trump’s War on Global Cinema: What the Future May Look Like For Foreign Films

Clayton Davis, Chief Awards Editor at Variety, helps us understand how the film industry could be greatly affected by Trump's tariff threats. Watch!

New Trade Deal Announced Between U.S. And U.K.

New Trade Deal Announced Between U.S. And U.K.

Bill Gates Plans To Donate 'Virtually All' Of His Wealth

Bill Gates Plans To Donate 'Virtually All' Of His Wealth

Big Business This Week: CVS nurses itself back to health

Shares are up more than 50% this year. Plus: Google, Apple, oil, Uber, Hollywood, and a fond farewell to the sage of Omaha.

Load More